Blog
RSS FeedPosted by Michael Wonder on 14 Jul 2020
Gilead rushes to meet remdesivir demand as virus pressures grow
15 July 2020 - Global pharmaceuticals giant Gilead has flagged the supply of its coronavirus treatment remdesivir will be constrained ...
Posted by Michael Wonder on 13 Jul 2020
TGA publishes more details on its approval of COVID-19 medicine Veklury
13 July 2020 - Remdesivir granted conditional approval in record time. ...
Posted by Michael Wonder on 12 Jul 2020
Australian vaccine trial starts today
13 July 2020 - Australian scientists are on track to deliver a COVID-19 vaccine this year, with the start on Monday ...
Posted by Michael Wonder on 11 Jul 2020
Australia's first COVID treatment approved
10 July 2020 - The Therapeutic Goods Administration has granted provisional approval to remdesivir (Veklury, Gilead Sciences) as the first ...
Posted by Michael Wonder on 02 Jul 2020
Gilead donates COVID-19 drug remdesivir to Australia’s medical stockpile after US buys up supply
2 July 2020 - The US pharmaceutical giant Gilead has donated a supply of the anti-viral medication remdesivir to Australia’s ...
Posted by Michael Wonder on 24 Jun 2020
US painkiller to be sold in Australian pharmacies to shore up supply
25 June 2020 - Global pharmaceutical giant Johnson & Johnson has been given approval to sell its US painkiller brand ...
Posted by Michael Wonder on 22 Jun 2020
Anti-COVID drug may be ready in Australia by the end of the year
21 June 2020 - A global breakthrough on a new antiviral drug that scientists believe could block the coronavirus has ...
Posted by Michael Wonder on 07 Jun 2020
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
5 June 2020 - A vaccine is anticipated to be available in 2021 if clinical trials are successful. ...
Posted by Michael Wonder on 28 May 2020
COVID-19: researchers halt patient recruitment for hydroxychloroquine trial
28 May 2020 - Australian researchers have suspended patient recruitment in a major clinical trial of the controversial anti-malaria drug ...
Posted by Michael Wonder on 28 May 2020
Australia avoids 'risky business' of coronavirus vaccine sweepstakes
27 May 2020 - Australia is avoiding huge financial risks by staying out of the global sweepstakes on coronavirus vaccines. ...
Posted by Michael Wonder on 26 May 2020
Australians stick with malaria drug hydroxychoroquine trial
26 May 2020 - Australian researchers are pressing ahead with administering the controversial antimalarial drug hydroxychloroquine in at least one ...
Posted by Michael Wonder on 18 May 2020
Australia must work to avoid 'vaccine nationalism', former top bureaucrat warns
18 May 2020 - A former top bureaucrat has warned the international race to develop a vaccine against the novel ...
Posted by Michael Wonder on 18 May 2020
COVID-19 vaccine frontrunners emerge as rollout debate rages
18 May 2020 - Governments and drug makers are weighing how to roll out coronavirus vaccines, including reserving the first ...
Posted by Michael Wonder on 07 May 2020
CSL Behring Australia commences development of treatment for serious cases of COVID-19
6 May 2020 - Plasma-derived therapeutic with potential to treat serious complications of COVID-19. ...
Posted by Michael Wonder on 06 May 2020
COVID-19: potentially life saving immunoglobulin treatment for seriously ill Australians
6 May 2020 - The Australian Government welcomes the announcement by CSL Behring that Australia will be one of the first ...